On paper Serbia's medical web looks large - over four million estimated benchmark visits* monthly. Once you unpack it, the story flips: the biggest domain is in fact the entire University of Belgrade (bg.ac.rs - students and faculties, not patients). Strip that out and roughly 700K benchmark visits of real medical care remain, led by clinics (MediGroup, Euromedik, Acibadem Bel Medic) and labs (Beo-lab, BioMedica, Aqualab). We show who owns which segment, where Serbia stands regionally, and why Romania is the mirror of the category's future.
*Benchmark visits are SEMrush Traffic Analytics estimates (panel-based market data), not actual GA4 sessions. The signal reflects interest and attention, not patient count.
How to read this report: All numbers are SEMrush estimates, not GA4 sessions. They reflect attention and intent, not patient count, revenue or retention. In medicine this matters more: the biggest headline domains are usually artifacts (a full university under one academic domain), retail e-commerce (pharmacies) and booking portals - not demand for a doctor. That is why we cross-check the signal three ways: top pages, Google reviews, and publicly filed revenue.
The biggest number in Serbia is an artifact, so let's start with the clean picture. bg.ac.rs carries 81% of the raw "share" (3.3M visits) - that's the entire University of Belgrade, students and faculties, not medical demand. Once removed - together with Philips (equipment manufacturer, not care provider) - the clean medical-care market in Serbia is around 700K visits monthly. It is led by clinics (MediGroup 189K, Euromedik 115K, Acibadem Bel Medic 68K) and labs (Beo-lab 100K, BioMedica, Aqualab).
In medicine you win with brand, direct relationships, and paid ads - not SEO blogs. AI Overviews are systematically draining the category, and the cleanest commercial signal belongs to players with strong direct traffic. Example: the Cvejanović implantology practice pulls 46K visits, 82% direct, backed by 2,200 Google reviews at 4.9. That is a strong personal brand. Large networks (MediGroup, Euromedik) achieve the same result through PPC and a private-insurance model.
Private practices are a live, separate segment. Specialist solo practices sum to 98.8K visits monthly and grow +11% month-on-month. Dental and solo-specialist practices dominate; dermatology and ophthalmology are web-invisible - those specialties transact offline through referral.
CRO and clinical research effectively don't exist on the web - neither in Serbia nor in the region. Croatia's largest CRO (Optimapharm, active in 29 countries) has 134 visits from HR; IQVIA in Serbia 2.7K; every domestic CRO is below the measurability threshold. Demand for clinical trials does not flow through the public web - it comes from pharma sponsors.
Health software is web-invisible in Serbia, even though elsewhere it sells through the web. Heliant, dominating with 280+ institutions, has just 538 visits - everything is sold through relationships. By contrast, Slovenian (Better, SRC) and Croatian (IN2, Ericsson NT) software has a web presence because it's export-oriented or portal-based, and Romanian (docbook, clickmed - booking marketplaces) is consumer-facing. It is a channel Serbian software still doesn't use.
Country-by-country, Serbia is a small market and Romania is huge. Measurable medical-care web traffic: Serbia ~0.7M visits monthly, Romania 7.5M, Croatia 338K, Slovenia 204K, N. Macedonia 67K, BiH 7.5K, Montenegro 6.4K. Romania is roughly ten times Serbia - not a competitor, a benchmark and a mirror. Consolidated Romanian networks (Regina Maria, MedLife, Synevo) run a full funnel with paid ads, email marketing, display and conversion tracking. Retail-grade medicine that nobody else in the region has reached yet.
Of 53 domains in the Serbian sample, 44 are measurable. The raw sample totals 4.1M visits, but one domain (bg.ac.rs, the whole university) accounts for 81% and that isn't medical demand. Once removed - along with Philips, which sells equipment rather than care - the clean market is roughly 709K visits. Here is what that looks like:
| # | Domain | Visits (K) | Share | Profile |
|---|---|---|---|---|
| 1 | medigroup.rs | 188.6 | 26.6% | clinics; largest private network |
| 2 | euromedic.rs | 115.2 | 16.3% | clinics; 15 sites |
| 3 | beo-lab.rs | 99.8 | 14.1% | lab; 40+ locations (Medicover/Synevo) |
| 4 | acibadembelmedic.rs | 68.4 | 9.6% | clinics; Acibadem/IHH |
| 5 | biomedicazavod.rs | 34.2 | 4.8% | lab; multi-city |
| 6 | aqualab.rs | 32.5 | 4.6% | lab; Synlab partner |
| 7 | kcs.ac.rs | 31.3 | 4.4% | UKC Serbia (partial university artifact) |
| 8 | bolnicaavala.rs | 15.7 | 2.2% | hospital; SEO spike warning (+834% organic) |
| 9 | poliklinikahuman.rs | 11.5 | 1.6% | polyclinic |
Private specialist practices are measured as a separate segment: 27 of 37 domains are measurable, totaling 98.8K visits monthly. That is more than the entire Croatian clinical segment. It is led by one implantology practice - Cvejanović at 46K visits (82% direct traffic, a sign of strong personal branding) - followed by internist Mediko (15.4K), ENT Žutić (11.6K), gynecologist Milenković (7.2K) and the largest dental chain Dental Plaza (4.1K). Dentistry and solo-brands dominate. Dermatology and ophthalmology practices are web-invisible - those specialties acquire patients through referral, not search.
Implantology, 82% direct - strong personal brand
The segment is growing month-on-month - the only one in this picture that's truly accelerating
Not measurable online - those specialties run on referral
"Medicine" in this analysis comprises six markets with very little in common. Clinics sell services to patients; labs sell analysis packages; private practices live on personal brand; CROs sell to pharma sponsors; medtech goes through tenders; software through relationships. We give the Serbian ranking and regional context for each.
Effectively absent from the web
IQVIA, PPD, Fortrea, Parexel, ICON (global); Cromos, EBS, MSB (RS); Optimapharm (HR). Demand does not come through the public web - it comes from pharma sponsors, tenders and networks of contacts. In Serbia the little traffic that exists is driven by institutes (kcs.ac.rs 31K, Batut 17K), not commercial CROs.
The cleanest consumer segment
Labs market analysis packages to patients and that is visible. In Serbia they hold 97% of the segment - Beo-lab (100K, Medicover/Synevo), BioMedica (34K), Aqualab (33K), Jugolab, MedLab. Imaging (radiology) is a thin slice. Konzilijum, despite being a large network, did not surface as measurable.
Top 3 hold 87% of the segment
Consumer segment with the biggest brands and the most traffic. Led by MediGroup (189K), Euromedik (115K) and Acibadem Bel Medic (68K). In Serbia it runs on direct traffic and organic search, without a serious funnel. Regionally, Romanian networks run a full funnel (Regina Maria 1.7M, MedLife 1.4M).
The only segment growing +11% MoM
A live, separate segment at 98.8K visits. Cvejanović (46K) holds almost half, followed by Mediko, Žutić, Milenković, Dental Plaza. Dentistry and solo-brands dominate. Dental-tourism brands (Marco, White Clinic) target foreign demand. Dermatology and ophthalmology - web-invisible.
Not sold through the web
As a care-provider segment it is nearly invisible. Philips (91K) excluded because it sells equipment, not care. What remains is distributors (Super-Lab, Vicor, Meding, Medisal, Trivax) and one domestic IVD manufacturer (Neomedica, 95 visits). Everything runs through tenders and B2B relationships.
Invisible in Serbia, not elsewhere
Heliant dominates with 280+ institutions and 40,000 users, yet has only 538 visits - everything is sold through relationships. Key contrast: Slovenian (Cosylab 11.7K, IN2 14.4K) software has a web presence because it's export-oriented or portal-based; Romanian (docbook 114K, clickmed 110K) is consumer-facing booking. It is a channel Serbian software does not yet use.
Serbia is the subject of this analysis; the other countries are a benchmark - a reference to see where we stand and where the category is heading. Nobody runs this region as one market; work happens country by country. Use this cross-section as a mirror for Serbia, and Romania in particular as an image of the category's future.
| Country | Measurable web (K) | Leads | Software on web? |
|---|---|---|---|
| Romania | 7,500 | Regina Maria 1.7M, MedLife 1.4M, Synevo 1.1M | Yes - booking marketplaces |
| Serbia* | ~700 | MediGroup, Euromedik, Beo-lab | No - Heliant 538 |
| Croatia | 338 | Sv. Katarina, Breyer, Medikol | Yes - IN2, Ericsson NT |
| Slovenia | 204 | Sanolabor (retail), physio/labs | Yes - Cosylab, SRC, Better |
| N. Macedonia | 67 | Zegin pharmacy holds 64% - retail | No / state |
| BiH | 7.5 | Eurofarm Centar 51% | Thin - emis, medisoft |
| Montenegro | 6.4 | KC CG 34%, Moj Lab | No (regional) |
Romania at 7.5M visits sits ten times above Serbia. No other market in the region carries this kind of weight; the others measure in hundreds of thousands or less.
Regina Maria and MedLife run paid search, paid social, email and display, with conversion tracking (Synevo 3.83%). That is retail marketing applied to medicine. Serbia is still on "brand + Google organic."
Slovenian and Croatian software have web presence because they are export-oriented or portal-based. Romanian (docbook, clickmed) is consumer-facing booking. In Serbia software sells through relationships - Heliant has 538 visits despite 280+ institutions.
The channel picture in medicine is narrow: Direct + Organic dominate almost all measurable traffic in Serbia, Slovenia and Croatia - the classic professional-services pattern. Paid search and display appear only among large networks and some practices; paid social almost exclusively among aesthetics and dental tourism; email marketing effectively only in Romania.
Cvejanović 82% direct - strong personal brand. MediGroup ~75% direct + organic, but also runs PPC. Beo-lab, Aqualab, BioMedica - Direct + Organic dominate. Bolnicaavala.rs shows a +834% organic jump (SEO tactics that require independent verification).
Conclusion: Serbian medicine doesn't grow through content. It grows through brand that lands directly, and through paid ads where budget exists.
Regina Maria: 874K direct + 777K organic + 15.8K paid search + 25.8K email. MedLife: 583K + 587K + 8.4K paid search. Synevo uses display and email at scale. Synevo.ro conversion rate: 3.83% - retail-grade, not the hospital average. Docbook (booking marketplace) 114K visits - a channel that does not exist elsewhere in the region.
This is the picture of where the category is heading - retail marketing applied to medicine.
Facebook/Instagram ads are almost exclusively a tool for aesthetics, dental tourism and dentistry. In Croatia, Bagatin is the largest advertiser in the category (97 active ads in Meta Ads Library, dominantly aesthetics). In Serbia a similar model is used by Dental Plaza, Belville, Marco Dental Tourism. General clinics and labs are almost absent from paid social - their demand comes through direct and organic. CROs, medtech and software are absent by definition.
Raw traffic in medicine is full of artifacts that look like demand but aren't. Before any serious decision, the signal must be validated through top pages, reviews and revenue. Here are six typical traps we found in this sample:
A domain with 3.3M visits accounting for 81% of the raw Serbian share. When you look at what's popular - faculty pages, admissions, exams. This is not medical demand, this is the entire University. Excluded from the analysis.
90K visits, but Philips sells devices to hospitals and consumer electronics rather than providing care. Doesn't belong in our care-provider sample.
UKC Serbia carries 31.3K visits. Part is real (patients seeking info), part is academic traffic tied to the medical faculty. Kept in the analysis, but with a caveat.
A single pharmacy chain holds 64% of total N. Macedonian "medical" traffic. This is not clinical demand - this is retail e-commerce. Same pattern as Sanolabor in Slovenia.
A short-term +834% jump in organic traffic is a tactical warning, not a business story. Before treating it as growth, verify independently that it isn't a viral or technical blip.
Konzilijum, a large Serbian private network, did not surface as measurable - despite being operationally significant. Cromos, EBS, MSB (Serbian CROs) - likewise below the measurability threshold. The message: large B2B businesses in this category do not need a large web footprint.
Web traffic is a leading signal (interest); reviews are trailing (experience after service). Read side-by-side, the dominance story changes. Web leader doesn't have to be retention leader - and vice versa.
| Brand | Reviews | Rating | Note |
|---|---|---|---|
| Cvejanović Dental (RS) | 2,200 | 4.9 | implantology - web leader confirmed by real-world experience |
| MediGroup flagship (RS) | 1,000 | 2.9 | 20+ branches - breadth, not depth |
| Acibadem Bel Medic (RS) | 830 | 3.2 | flagship hospital |
| Bagatin (HR) | 558 | 4.6 | aesthetics, Zagreb flagship |
| Synevo (RO, labs) | 300 | 4.8 | labs >> networks by rating |
| Regina Maria (RO) | 2,500 | 3.0 | 50+ centers - scale without satisfaction |
| MedLife (RO) | 2,500 | 2.5 | 30+ hyperclinics |
46K visits, 2,200 reviews averaging 4.9. The web leader in private practices is validated by real-world experience. This is the model that works.
189K visits and 20+ branches, but the flagship scores 2.9 on 1,000 reviews. Web leader doesn't mean retention leader. Same pattern with Romanian giants - Regina Maria 3.0 and MedLife 2.5 on 2,500+ reviews.
Synevo (RO) scores 4.8; Beo-lab in Serbia runs a standardized protocol. Labs are more transactional than clinical care, the experience is more consistent, hence the higher scores. Aesthetics (Bagatin 4.6) also scores high because it lives on referral.
There is no single winning strategy in medicine - the segment defines the channel. But the shared point is this: SEO blogs are losing ground (AI Overviews drain them), and the winners are brand, direct relationships and, where possible, a complete funnel modeled on Romania.
Regina Maria, MedLife and Synevo show what a mature funnel looks like: paid search for top-of-funnel demand, display and social for attention, email for retention, and conversion tracking (Synevo 3.83%). Serbian clinics (MediGroup, Euromedik, Acibadem) sit at "brand + PPC"; the next step is consumer-grade CRM and conversion marketing.
Investment: CRM, martech stack, full-funnel paid.
Optimapharm (HR CRO active in 29 countries) has 134 visits from HR; Heliant with 280+ institutions has 538 visits. The message is clear: large B2B deals in these segments aren't won through the web. Investment goes into account-based selling, tenders, references and conferences. The web is a business card, not a lead machine.
Exception: booking marketplaces (docbook, clickmed) - a channel Serbia hasn't opened.
Cvejanović (46K, 82% direct) and Bagatin (Zagreb, 558 reviews at 4.6) show that a specialized, recognizable brand beats scale. When AI Overviews eat SEO articles, what remains is what people search by name. That is why investment in PR, physician authorship and patient experience pays back better than the blog in this category.
Investment: brand, patient experience, Google reviews, physician authority.
APR and publicly available registers give a picture that doesn't match the web. The largest by traffic isn't necessarily the largest by revenue - and the largest by revenue is often a foreign investor who doesn't communicate through the web at all.
| Brand | Revenue (M €) | Staff | Web rank | Ownership / operational note |
|---|---|---|---|---|
| Euromedik (DZ) | 32.6 | 581 | #2 | Serbian; LARGEST single entity |
| MediGroup (hospital) | 24.7 | 367 | #1 | Regina Maria → Mehilainen (FI) |
| Acibadem Bel Medic | 16.7 | - | #4 | Acibadem / IHH (TR/MY) |
| Neomedica Niš | 5.0 | 94 | - | IVD manufacturer, exports |
| Konzilijum | 4.5 | - | - | Serbian private, did not surface as measurable |
| Heliant | 2.8 | 40 | - | software for 280+ institutions |
| Beo-lab / Aqualab | - | - | #3 | Medicover AB (Nasdaq, €2.09bn) |
As a single entity, Euromedik is Serbia's largest private healthcare brand by revenue (~€32.6M, 581 staff), but only second on the web. The model: private insurance + corporate clients, instead of a consumer funnel.
Their true size isn't visible in Serbian registers because they are part of Medicover AB - a Swedish Nasdaq-listed company with €2.09bn group revenue. Same pattern: MediGroup is part of Mehilainen (Finland), Acibadem Bel Medic is part of IHH group (Turkey/Malaysia).
€5M revenue, 94 staff, present in 34 markets. A domestic in-vitro diagnostics product - but no web rank because sales go through distributors and B2B channels. Classic "big business, small web".
280+ institutions, 40,000 users, €2.8M revenue, 40 staff. All of it built through institutional relationships. 538 site visits is proof that in this segment the web serves as a business card, not a sales channel.
SEMrush doesn't see Facebook/Instagram ads. Meta Ads Library shows them publicly. Our cross-check confirms the channel pattern from Section 5: aesthetics and dental tourism lead paid social, large chains use it selectively, other segments barely touch it.
97 active ads, almost exclusively aesthetics. The business model - dental and medical tourism - depends directly on visibility to foreign audiences, so paid social is a revenue foundation, not an add-on.
45 active ads, with an interesting finding - part of it is a co-brand campaign with Yettel (telco). Signal that telecom operators are entering healthcare marketing as partners, a model imported from Nordic markets.
Beo-lab, Aqualab and BioMedica don't advertise continuously but show pronounced spikes when they release packages (annual check-up, hormonal panels). The channel is used tactically, not permanently.
These segments practically don't exist in Meta Ads Library. There is no commercial sense in advertising B2B clinical research or HIS software on Instagram. Confirmation that "medicine" in this analysis is in fact six separate markets.
SEMrush Traffic Analytics, July 2026. Panel-based visit and channel-mix estimates, not GA4. Signal is leading (interest), not trailing (revenue). All figures move within ±20-30% depending on source methodology.
~300 domains across seven countries (RS, RO, HR, SI, MK, BiH, ME), grouped into six segments: CRO, labs, clinics, private practices, medtech, software. Serbia is the subject, the others are the benchmark. Measurable = domain has detectable traffic above threshold.
One legal entity can operate many domains; a single domain (bg.ac.rs) can cover many entities. That is why we aggregated at the root-domain level and manually excluded artifacts (university, OEM equipment maker, retail pharmacy where it conflicts with care).
Every conclusion was validated through: (1) Top pages - do the most-visited pages confirm the category; (2) Google reviews - trailing experience signal; (3) public financial registers (APR and equivalents) - does the web leader match the actual size of the business.
This analysis covers medicine as a whole - clinics, labs, private practices, CRO, medtech and software. On request we run more granular cuts (gynecology, dentistry, dermatology, diagnostic imaging - CT, MRI, ultrasound, a specific specialty or chain) as well as multi-month and yearly trend analyses that show who grew, who lost ground and how the channel mix shifted over time. Reach out if you need that kind of cut for your company or an investment decision.
Contact us